Players investigating the Red Dead Redemption 2 spiderweb easter egg chain believe they've uncovered the next step in ...

Geron Corporation (NASDAQ:GERN) is one of the best long-term penny stocks to invest in. Geron Corporation (NASDAQ:GERN) announced on December 8 that new data was presented at the 67th American Society ...

Geron (GERN) remains a Hold as Rytelo sales growth underwhelms amid fierce competition and complex treatment landscapes in MDS and myelofibrosis. Recent strategic restructuring, including a one-third ...

An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models. The consensus rating for Geron is "Buy", based on ...

This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.

Geron Corporation (GERN) on Thursday announced plans to lay off nearly a third of its 260 employees as part of a major restructuring initiative under the newly appointed CEO, Harout Semerjian. The ...

Interactive Chart for Geron Corporation (GERN), analyze all the data with a huge range of indicators.

Chart does not reflect overnight price.

Geron Corp. Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology.